BAIRD MEDICAL INVESTMENT HOLDINGS LIMITED

NASDAQ: BDMD (Baird Medical Investment Holdin)

Kemas kini terakhir: 22 Nov, 6:23AM

1.41

-0.10 (-6.62%)

Penutupan Terdahulu 1.51
Buka 1.54
Jumlah Dagangan 112,666
Purata Dagangan (3B) 301,362
Modal Pasaran 52,192,416
Harga / Pendapatan (P/E TTM) 2.88
Harga / Jualan (P/S) 1.13
Harga / Buku (P/B) 1.52
Julat 52 Minggu
1.02 (-27%) — 12.50 (786%)
Tarikh Pendapatan 15 May 2025
Margin Keuntungan 33.62%
Margin Operasi (TTM) 42.79%
EPS Cair (TTM) 0.490
Pertumbuhan Hasil Suku Tahunan (YOY) 20.00%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -1.10%
Jumlah Hutang/Ekuiti (D/E MRQ) 52.51%
Nisbah Semasa (MRQ) 1.77
Aliran Tunai Operasi (OCF TTM) -6.31 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -4.00 M
Pulangan Atas Aset (ROA TTM) 14.21%
Pulangan Atas Ekuiti (ROE TTM) 33.39%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Bercampur
Medical Devices (Global) Bercampur Bercampur
Stok Baird Medical Investment Holdin - -

AISkor Stockmoo

0.4
Konsensus Penganalisis 0.0
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal -1.0
Osilator Teknikal 2.0
Purata 0.38

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
BDMD 52 M - 2.88 1.52
CBLL 630 M - - 3.83
MGRM 244 M - - -
ADGM 17 M - - 3.57
DHAI 2 M - - 3.03
DXCM 26 B - 36.38 9.28

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Sektor Healthcare
Industri Medical Devices
% Dimiliki oleh Orang Dalam 99.92%
% Dimiliki oleh Institusi 1.40%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
08 Dec 2025 Pengumuman Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon
03 Dec 2025 Pengumuman Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
03 Nov 2025 Pengumuman Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
27 Oct 2025 Pengumuman Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
23 Oct 2025 Pengumuman Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
21 Oct 2025 Pengumuman /C O R R E C T I O N -- BDMD/
20 Oct 2025 Pengumuman Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
16 Oct 2025 Pengumuman Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
14 Oct 2025 Pengumuman Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
09 Oct 2025 Pengumuman Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
06 Oct 2025 Pengumuman Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress
01 Oct 2025 Pengumuman Baird Medical Advances Microwave Ablation Training at Leading U.S. Thyroid Centers
29 Sep 2025 Pengumuman Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda